open access

Vol 92, No 11 (2021)
Guidelines / Expert consensus
Published online: 2021-11-10
Get Citation

Urogynecology Section of the Polish Society of Gynecologists and Obstetricians guidelines on the management of stress urinary incontinence in women

Klaudia Stangel-Wojcikiewicz1, Artur Rogowski23, Tomasz Rechberger4, Wlodzimierz Baranowski5, Magdalena E. Grzybowska6, Tomasz Kluz7, Elzbieta Narojczyk-Swiesciak8, Edyta Wlazlak9, Bartlomiej Burzynski10, Grzegorz Surkont9
DOI: 10.5603/GP.a2021.0206
·
Ginekol Pol 2021;92(11):822-828.
Affiliations
  1. Department of Gynecology and Oncology, Jagiellonian University Medical College, Cracow, Poland
  2. Department of Gynecology, „Inflancka” Specialist Hospital, Warsaw, Poland
  3. Collegium Medicum, Cardinal Stefan Wyszynski University, Warsaw, Poland
  4. II Department of Gynecology, Medical University of Lublin, Poland
  5. Department of Gynecology, Gynecological Oncology, Military Medical Institute, Warsaw, Poland
  6. Department of Gynecology, Gynecological Oncology and Gynecological Endocrinology, Medical University of Gdansk, Poland
  7. Clinic of Gynecology and Obstetrics, Institute of Medical Science, College of Medical Science, University of Rzeszow, Poland
  8. II Department of Gynecology and Obstetrics, Bielanski Hospital Warsaw, Poland
  9. Department of Operative Gynecology and Gynecological Oncology, I Department of Gynecology and Obstetrics, Medical University of Lodz, Poland
  10. Department of Rehabilitation, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland

open access

Vol 92, No 11 (2021)
RECOMMENDATIONS
Published online: 2021-11-10

Abstract

Objectives: The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the management of stress urinary incontinence (SUI).
Material and methods: A review of the literature, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, about the treatment of SUI was conducted.
Results: Management of SUI is presented. Four lines of therapy were identified: line 1 — the so-called ‘conservative treatment’, which should always be attempted, regardless of SUI symptom severity; line 2 — surgical intervention; lines 3 and 4 — reoperations after unsuccessful surgeries from line 2. The literature reports which provided supporting evidence for this Guideline, including the practical aspects, were discussed.
Conclusions: A systematic review of the guidelines and an analysis of SUI management were conducted. The need for an individualized approach was emphasized.

Abstract

Objectives: The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the management of stress urinary incontinence (SUI).
Material and methods: A review of the literature, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, about the treatment of SUI was conducted.
Results: Management of SUI is presented. Four lines of therapy were identified: line 1 — the so-called ‘conservative treatment’, which should always be attempted, regardless of SUI symptom severity; line 2 — surgical intervention; lines 3 and 4 — reoperations after unsuccessful surgeries from line 2. The literature reports which provided supporting evidence for this Guideline, including the practical aspects, were discussed.
Conclusions: A systematic review of the guidelines and an analysis of SUI management were conducted. The need for an individualized approach was emphasized.

Get Citation

Keywords

urinary incontinence, stress urinary incontinence, conservative treatment, physiotherapy, surgical treatment, midurethral sling, colposuspension

About this article
Title

Urogynecology Section of the Polish Society of Gynecologists and Obstetricians guidelines on the management of stress urinary incontinence in women

Journal

Ginekologia Polska

Issue

Vol 92, No 11 (2021)

Article type

Guidelines / Expert consensus

Pages

822-828

Published online

2021-11-10

DOI

10.5603/GP.a2021.0206

Bibliographic record

Ginekol Pol 2021;92(11):822-828.

Keywords

urinary incontinence
stress urinary incontinence
conservative treatment
physiotherapy
surgical treatment
midurethral sling
colposuspension

Authors

Klaudia Stangel-Wojcikiewicz
Artur Rogowski
Tomasz Rechberger
Wlodzimierz Baranowski
Magdalena E. Grzybowska
Tomasz Kluz
Elzbieta Narojczyk-Swiesciak
Edyta Wlazlak
Bartlomiej Burzynski
Grzegorz Surkont

References (56)
  1. Haylen BT, de Ridder D, Freeman RM, et al. International Urogynecological Association, International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010; 29(1): 4–20.
  2. Wlaźlak E, Surkont G, Shek KaL, et al. Can we predict urinary stress incontinence by using demographic, clinical, imaging and urodynamic data? Eur J Obstet Gynecol Reprod Biol. 2015; 193: 114–117.
  3. Bettez M, Tu LeM, Carlson K, et al. 2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association. Can Urol Assoc J. 2012; 6(5): 354–363.
  4. Nambiar AK, Bosch R, Cruz F, et al. Asociación Europea de Urología, European Association of Urology. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2012; 62(6): 1130–1142.
  5. Fabian G, Kociszewski J, Kuszka A, et al. Vaginal excision of the sub-urethral sling: analysis of indications, safety and outcome. Arch Med Sci. 2015; 11(5): 982–982.
  6. Giarenis I, Mastoroudes H, Cardozo L, et al. What do we do when a midurethral tape fails? Rediscovery of open colposuspension as a salvage continence operation. International Urogynecology Journal. 2012; 23(8): 1117–1122.
  7. Surkont G, Wlaźlak E, Petri E, et al. Standardized modified colposuspension--mid-term results of prospective studies in one centre. Ann Agric Environ Med. 2015; 22(2): 293–296.
  8. Wein AJ. Committee Opinion No. 603: Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Obstet Gynecol. 2014; 123(6): 1403–1407.
  9. Teunissen TAM, Lagro-Janssen ALM. Sex differences in the use of absorbent (incontinence) pads in independently living elderly people: do men receive less care? Int J Clin Pract. 2009; 63(6): 869–873.
  10. Sarma AV, Kanaya A, Nyberg LM, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology. 2009; 73(6): 1203–1209.
  11. Bryant CM, Dowell CJ, Fairbrother G. Caffeine reduction education to improve urinary symptoms. Br J Nurs. 2002; 11(8): 560–565.
  12. Fuselier A, Hanberry J, Margaret Lovin J, et al. Obesity and stress urinary incontinence: impact on pathophysiology and treatment. Curr Urol Rep. 2018; 19(1): 10.
  13. National Collaborating Centre for Women's and Children's Health (UK). Urinary Incontinence in Women: The Management of Urinary Incontinence in Women. London: Royal College of Obstetricians and Gynecologists (UK); 2013.
  14. Nambiar AK, Bosch R, Cruz F, et al. Asociación Europea de Urología, European Association of Urology. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2012; 62(6): 1130–1142.
  15. Whitcomb EL, Subak LL. Effect of weight loss on urinary incontinence in women. Open Access J Urol. 2011; 3: 123–132.
  16. Kaplan SA, Dmochowski R, Cash BD, et al. Systematic review of the relationship between bladder and bowel function: implications for patient management. Int J Clin Pract. 2013; 67(3): 205–216.
  17. Carvalhais A, Natal Jorge R, Bø K. Performing high-level sport is strongly associated with urinary incontinence in elite athletes: a comparative study of 372 elite female athletes and 372 controls. Br J Sports Med. 2018; 52(24): 1586–1590.
  18. Nygaard IE. Does prolonged high-impact activity contribute to later urinary incontinence? A retrospective cohort study of female Olympians. Obstet Gynecol. 1997; 90(5): 718–722.
  19. Hannestad YS, Rortveit G, Daltveit AK, et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG. 2003; 110(3): 247–254.
  20. Fantl JA, Wyman JF, Harkins SW, et al. Bladder training in the management of lower urinary tract dysfunction in women. A review. J Am Geriatr Soc. 1990; 38(3): 329–332.
  21. Marques A, Stothers L, Macnab A. The status of pelvic floor muscle training for women. Can Urol Assoc J. 2010; 4(6): 419–424.
  22. Dumoulin C, Cacciari LP, Hay-Smith EJ. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018; 10: CD005654.
  23. Cundiff GW, Weidner AC, Visco AG, et al. A survey of pessary use by members of the American urogynecologic society. Obstet Gynecol. 2000; 95(6 Pt 1): 931–935.
  24. Donnelly MJ, Powell-Morgan S, Olsen AL, et al. Vaginal pessaries for the management of stress and mixed urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2004; 15(5): 302–307.
  25. Wlaźlak E, Krzycka M, Surkont G. Wysiłkowe nietrzymanie moczu-leczenie zachowawcze, pessaroterapia. In: Baranowski, W, Rogowski A. ed. Uroginekologia. Medical Tribune : 254–265.
  26. Maund E, Guski LS, Gøtzsche PC. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. CMAJ. 2017; 189(5): E194–E203.
  27. Historical information on duloxetine hydrochloride (marketed as Cymbalta). Silver Spring (MD): Food and Drug Administration (US); 2013. www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm114970htm (2016 May 30).
  28. Cody JD, Jacobs ML, Richardson K, et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012; 10: CD001405.
  29. Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn. 2011; 30(5): 754–757.
  30. Donders GGG, Ruban K, Bellen G, et al. Pharmacotherapy for the treatment of vaginal atrophy. Expert Opin Pharmacother. 2019; 20(7): 821–835.
  31. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005; 293(8): 935–948.
  32. Lemos N, Korte JE, Iskander M, et al. Center-by-center results of a multicenter prospective trial to determine the inter-observer correlation of the simplified POP-Q in describing pelvic organ prolapse. Int Urogynecol J. 2012; 23(5): 579–584.
  33. Kluz T, Wlaźlak E, Surkont G. Transvaginal six-arm mesh OPUR in women with apical pelvic organ prolapse - analysis of short-term results, pelvic floor ultrasound evaluation. Ginekol Pol. 2017; 88(6): 302–306.
  34. Amid PK. Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia. 1997; 1(1): 15–21.
  35. Klinge U, Klosterhalfen B. Modified classification of surgical meshes for hernia repair based on the analyses of 1,000 explanted meshes. Hernia. 2012; 16(3): 251–258.
  36. Surkont G, Wlaźlak E, Suzin J. Long-term risk of complications after mid-urethral sling IVS implantation. Ann Agric Environ Med. 2015; 22(1): 163–166.
  37. Kowalik CG, Dmochowski RR, De EJB. Surgery for female SUI: The ICI algorithm. Neurourol Urodyn. 2019; 38 Suppl 4: S21–S27.
  38. Delorme E. [Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women]. Prog Urol. 2001; 11(6): 1306–1313.
  39. Wlaźlak E, Viereck V, Kociszewski J, et al. Role of intrinsic sphincter deficiency with and without urethral hypomobility on the outcome of tape insertion. Neurourol Urodyn. 2017; 36(7): 1910–1916.
  40. Wlaźlak E, Kluz T, Kociszewski J, et al. The analysis of repeatability and reproducibility of bladder neck mobility measurements obtained during pelvic floor sonography performed introitally with 2D transvaginal probe. Ginekol Pol. 2017; 88(7): 360–365.
  41. Wlaźlak E, Kluz T, Surkont G, et al. Urethral funneling visualized during pelvic floor sonography - analysis of occurrence among urogynecological patients. Ginekol Pol. 2018; 89(2): 55–61.
  42. Kuszka A, Rautenberg O, Wlaźlak E, et al. Do different vaginal tapes need different suburethral incisions? The one-half rule. Neurourol Urodyn. 2015; 34(8): 741–746.
  43. Kociszewski J, Rautenberg O, Kuszka A, et al. Can we place tension-free vaginal tape where it should be? The one-third rule. Ultrasound Obstet Gynecol. 2012; 39(2): 210–214.
  44. Surkont G, Wlaźlak E, Dunicz-Sokolowska A, et al. [The efficacy of SUI treatment with Burch colposuspension evaluated with use of ITT analysis]. Ginekol Pol. 2007; 78(5): 378–380.
  45. Oliveira LM, Dias MM, Martins SB, et al. Surgical treatment for stress urinary incontinence in women: A systematic review and meta-analysis. Rev Bras Ginecol Obstet. 2018; 40(8): 477–490.
  46. Asıcıoglu O, Gungorduk K, Besımoglu B, et al. A 5-year follow-up study comparing Burch colposuspension and transobturator tape for the surgical treatment of stress urinary incontinence. Int J Gynaecol Obstet. 2014; 125(1): 73–77.
  47. Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017; 7: CD006375.
  48. Kuhn A, Stadlmayr W, Lengsfeld D, et al. Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct. 2008; 19(6): 817–821.
  49. Hegde A, Smith AL, Aguilar VC, et al. Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent. Int Urogynecol J. 2013; 24(7): 1151–1159.
  50. Leone Roberti Maggiore U, Bogani G, Meschia M, et al. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015; 189: 48–54.
  51. Mahdy A, Ghoniem GM. Autologous rectus fascia sling for treatment of stress urinary incontinence in women: A review of the literature. Neurourol Urodyn. 2019; 38 Suppl 4: S51–S58.
  52. Alonso Ro, Fes As, Fernandez Barranco L, et al. Four-year experience with the flowsecure artificial urinary sphincter. Problems and solution. Neurol Urodyn. 2011; 30: 250.
  53. Stangel-Wojcikiewicz K, Piwowar M, Jach R, et al. Quality of life assessment in female patients 2 and 4 years after muscle-derived cell transplants for stress urinary incontinence treatment. Ginekol Pol. 2016; 87(3): 183–189.
  54. Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, et al. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: A 2-year follow-up of a polish investigation. Neurourology and Urodynamics. 2013; 33(3): 324–330.
  55. Stangel-Wójcikiewicz K. egenerative Medicine for the Treatment of Urinary Incontinence. Jagiellonian University Press .
  56. Peters KM, Dmochowski RR, Carr LK, et al. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol. 2014; 192(2): 469–476.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl